Funding M&A MedTech

How is COVID-19 affecting medtech deals?

Fewer medical device companies are securing their first big venture capital investments — or engaging in large mergers — amid the COVID-19 pandemic, according to recently released reports from Silicon Valley Bank and PwC.

The medical device industry saw 38 Series A investments worth $279 million during the first half of 2020, down from 45 deals worth $408 million during the same period a year ago, according to SVB’s new mid-year “Healthcare Investments and Exits” report.

Meanwhile, PwC reports that the volume and value of medical device M&A deals decreased during the first half of the year. There were 28 medtech M&A deals worth $1.9 billion during the first six months of 2020, versus 38 deals worth $15.4 billion during the previous six months.

The numbers are but another indication that the medical device industry is not immune to the effects of the pandemic and the resulting recession.

Even as the reports paint a picture of caution in the industry during the first half of the year, there were also bright spots. Go to our sister site Medical Design & Outsourcing to find out more. 

Original Article: (https://www.massdevice.com/how-is-covid-19-affecting-medtech-deals/)

Written by

MassDevice
s